Diabetes Clinical Care

Activity Description

CME Release Date: April 24, 2011
CME Expiration Date: April 24, 2012

Statement of Need

Because the majority of people with diabetes are cared for by their primary care providers, PCPs need a comprehensive review and update on diabetes management to provide optimal care. Advances in Diabetes, an annual CME course, initiated more than century ago by Elliott P. Joslin, MD, in conjunction with Harvard Medical School, is the longest-running continuously offered academic course in diabetes in the United States and, likely, the world. The course has evolved with diabetes practice and research as well as the changing continuing education needs of the medical profession.

This Internet enduring material was developed from the following presentations by the faculty on November 11, 2010 at the Advances in Diabetes 2010 course in Boston, MA.

  1. Gestational Diabetes, Pregnancy, and Metabolic care: Overlapping concerns
    Florence M. Brown, MD
  2. The Role of the Liver in Diabetes and Metabolic Disease: Clinical Perspectives
    Nezam H. Afdhal M.D
  3. Diabetes in Children and Adolescents: Challenges and Solutions
    Lori Laffel, MD, MPH

Target Audience

This certified activity was developed for primary care providers with a practice population that includes significant numbers of people with diabetes.

Learning Objectives

After participating in this educational activity, healthcare professionals should be able to:
  1. Explain the 1-step criteria for GDM diagnosis per the International Association of Diabetes and Pregnancy Study Groups recommendations.
  2. Treat and manage gestational diabetes with diet, exercise and medication.
  3. Recognize the importance of the control of diabetes and insulin resistance as part of for hepatitis C virus therapy.

Faculty and Disclosures

Florence M. Brown, MD
Assistant Professor of Medicine
Harvard Medical School
Co-Director, Diabetes and Pregnancy Program
Joslin Diabetes Center
Beth Israel Deaconess Medical Center
Boston, MA

Disclosure: Dr. Florence M. Brown has no relevant financial relationships.

Nezam H. Afdhal M.D.
Associate Professor of Medicine
Harvard Medical School
Director, Liver center
Beth Israel Deaconess Medical Center

Disclosure: Dr. Nezam Afdhal receives grant/research support from Echosens, Gilead Sciences, Inc., GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Quest Diagnostics Incorporated, Schering-Plough/Merck, and Vertex Pharmaceuticals Incorporated; and is on the advisory board for Biogen Idec, Biolex, Inc., Boehrnger Ingelheim Pharmaceuticals, Inc., Echosens, FibroGen, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Human Genome Sciences, Inc., Idera Pharmaceuticals Inc., Ligand Pharmaceuticals, Novartis Pharmaceuticals Corporation, and Vertex Pharmaceuticals Incorporated.

Lori Laffel, MD, MPH
Associate Professor of Pediatrics
Harvard Medical School
Chief, Pediatric, Adolescent and Young Adult Section
Investigator, Genetics and Epidemiology Section
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Lori M. Laffel is on the speakers bureau for Abbott Diabetes Care, Inc., Eli Lilly and Company, Johnson & Johnson, The Menarini Group, Novo Nordisk Inc., Roche Diagnostics, and sanofi-aventis U.S. LLC; is a consultant for Abbott Diabetes Care, Inc., Bayer, Bristol-Myers Squibb Company, Eli Lilly and Company, Medtronic MiniMed, Inc., The Menarini Group, and Roche Diagnostics; and receives research/grant support from Medtronic MiniMed, Inc.

Planning Committee:

Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director and Senior Vice President
Joslin Diabetes Center
Boston, MA

Disclosure: Dr. Martin J. Abrahamson is on the advisory board for Halozyme Therapeutics, Merck & Co., Inc., Novo Nordisk Inc., and sanofi-aventis U.S. LLC, and receives grant/research support from Pfizer Inc.

Richard S. Beaser, MD
Associate Clinical Professor of Medicine
Harvard Medical School
Medical Executive Director
Professional Education
Joslin Diabetes Center

Disclosure: Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for CeQur Ltd.

Accreditation and Designation of Credit

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The Harvard Medical School designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants not eligible for CME credit will receive a certificate of completion.

Computer Requirements

To participate in this activity, your computer will need the following hardware and software:

PC Users:
Macintosh Users System OS X:
Credit Instructions
  1. Read the learning objectives, accreditation information, and faculty disclosures at the beginning of the activity.
  2. Click on the link below to register for the Webcast and view the online video and slides
  3. Complete the online posttest and evaluation.
  4. Physicians who receive a grade of 60% or better on the posttest and who complete the evaluation will receive a CME certificate as a PDF sent to their email address.
  5. All other participants who receive a grade of 60% or better on the posttest and who complete the evaluation will receive a certificate of completion as a PDF sent to their email address.

Questions About This Activity

For questions regarding this activity, including technical support, please contact cme@joslin.harvard.edu.

To read the policy on privacy and confidentiality that relates to the CME activity, click here.